Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zehong Wan

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|March 29, 2018
Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Luigi Piero Stasi, Ming-Hsun Ho, et al.
Journal of Medicinal Chemistry|September 19, 2008
Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonistsJian Jin, Brian Budzik, Yonghui Wang, et al.
Journal of Medicinal Chemistry|July 28, 2009
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Zehong Wan, Hongxing Yan, et al.
Neuropharmacology|March 15, 2013
Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivoYunhong Huang, Ting Li, Andrew Eatherton, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Pyridazine-derived γ-secretase modulatorsZehong Wan, Adrian Hall, Yun Jin, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacyXiao Ding, Luigi Piero Stasi, Xuedong Dai, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2017
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Xuedong Dai, Kai Long, et al.
Journal of Medicinal Chemistry|December 10, 2016
Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>)Alison J-A Woolford, Philip J Day, Véronique Bénéton, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2012
Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Hongxing Yan, Haibo Xie, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2011
Pyridine-derived γ-secretase modulatorsZehong Wan, Adrian Hall, Yingxia Sang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry Letters|March 29, 2018
Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Luigi Piero Stasi, Ming-Hsun Ho, et al.
Journal of Medicinal Chemistry|September 19, 2008
Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonistsJian Jin, Brian Budzik, Yonghui Wang, et al.
Journal of Medicinal Chemistry|July 28, 2009
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Zehong Wan, Hongxing Yan, et al.
Neuropharmacology|March 15, 2013
Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivoYunhong Huang, Ting Li, Andrew Eatherton, et al.
Bioorganic & Medicinal Chemistry Letters|June 4, 2011
Pyridazine-derived γ-secretase modulatorsZehong Wan, Adrian Hall, Yun Jin, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacyXiao Ding, Luigi Piero Stasi, Xuedong Dai, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2017
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitorsXiao Ding, Xuedong Dai, Kai Long, et al.
Journal of Medicinal Chemistry|December 10, 2016
Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub>2</sub>)Alison J-A Woolford, Philip J Day, Véronique Bénéton, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2012
Design, synthesis and structure-activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonistsDramane I Lainé, Hongxing Yan, Haibo Xie, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2011
Pyridine-derived γ-secretase modulatorsZehong Wan, Adrian Hall, Yingxia Sang, et al.
Pageof 2